BIA member Summit Therapeutics has released a video interview with Professor Mark Wilcox, Consultant Microbiologist & Head of Microbiology at the Leeds Teaching Hospitals NHS Trust, Professor of Medical Microbiology at the University of Leeds, and Public Health England’s Lead on C. difficile in England.
In the video, Professor Wilcox talks about the challenges in treating C. difficile infection and looks at the potential of the investigational antibiotic ridinilazole. Find out more by clicking on the video below.
Do you have a video you would like the sector to see? Contact us.